BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38367651)

  • 1. Partial volume correction in longitudinal tau PET studies: is it really needed?
    Costoya-Sánchez A; Moscoso A; Sobrino T; Ruibal Á; Grothe MJ; Schöll M; Silva-Rodríguez J; Aguiar P;
    Neuroimage; 2024 Apr; 289():120537. PubMed ID: 38367651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of spill-in counts from off-target regions on [
    López-González FJ; Costoya-Sánchez A; Paredes-Pacheco J; Moscoso A; Silva-Rodríguez J; Aguiar P;
    Neuroimage; 2022 Oct; 259():119396. PubMed ID: 35753593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
    Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR;
    JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation.
    Schwarz CG; Therneau TM; Weigand SD; Gunter JL; Lowe VJ; Przybelski SA; Senjem ML; Botha H; Vemuri P; Kantarci K; Boeve BF; Whitwell JL; Josephs KA; Petersen RC; Knopman DS; Jack CR
    Neuroimage; 2021 Sep; 238():118259. PubMed ID: 34118395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease.
    Thomas BA; Erlandsson K; Modat M; Thurfjell L; Vandenberghe R; Ourselin S; Hutton BF
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1104-19. PubMed ID: 21336694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
    Leuzy A; Binette AP; Vogel JW; Klein G; Borroni E; Tonietto M; Strandberg O; Mattsson-Carlgren N; Palmqvist S; Pontecorvo MJ; Iaccarino L; Stomrud E; Ossenkoppele R; Smith R; Hansson O;
    JAMA Neurol; 2023 Jun; 80(6):614-623. PubMed ID: 37155176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting future rates of tau accumulation on PET.
    Jack CR; Wiste HJ; Weigand SD; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Ferman TJ; Boeve BF; Kantarci K; Vemuri P; Mielke MM; Whitwell J; Josephs K; Schwarz CG; Senjem ML; Gunter JL; Petersen RC
    Brain; 2020 Oct; 143(10):3136-3150. PubMed ID: 33094327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal.
    Lee CM; Jacobs HIL; Marquié M; Becker JA; Andrea NV; Jin DS; Schultz AP; Frosch MP; Gómez-Isla T; Sperling RA; Johnson KA
    J Alzheimers Dis; 2018; 62(4):1691-1702. PubMed ID: 29614677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Off-Target Binding on
    Baker SL; Harrison TM; Maass A; La Joie R; Jagust WJ
    J Nucl Med; 2019 Oct; 60(10):1444-1451. PubMed ID: 30877180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spill-in counts in the quantification of
    López-González FJ; Moscoso A; Efthimiou N; Fernández-Ferreiro A; Piñeiro-Fiel M; Archibald SJ; Aguiar P; Silva-Rodríguez J;
    EJNMMI Phys; 2019 Dec; 6(1):27. PubMed ID: 31858289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of a [
    Coomans EM; de Koning LA; Rikken RM; Verfaillie SCJ; Visser D; den Braber A; Tomassen J; van de Beek M; Collij LE; Lemstra AW; Windhorst AD; Barkhof F; Golla SSV; Visser PJ; Scheltens P; van der Flier WM; Ossenkoppele R; van Berckel BNM; van de Giessen E
    Neurology; 2023 Nov; 101(19):e1850-e1862. PubMed ID: 37748892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts.
    Provost K; Iaccarino L; Soleimani-Meigooni DN; Baker S; Edwards L; Eichenlaub U; Hansson O; Jagust W; Janabi M; La Joie R; Lesman-Segev O; Mellinger TJ; Miller BL; Ossenkoppele R; Pham J; Smith R; Sonni I; Strom A; Mattsson-Carlgren N; Rabinovici GD;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2259-2271. PubMed ID: 33398408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment.
    Mundada NS; Rojas JC; Vandevrede L; Thijssen EH; Iaccarino L; Okoye OC; Shankar R; Soleimani-Meigooni DN; Lago AL; Miller BL; Teunissen CE; Heuer H; Rosen HJ; Dage JL; Jagust WJ; Rabinovici GD; Boxer AL; La Joie R
    Alzheimers Res Ther; 2023 Sep; 15(1):157. PubMed ID: 37740209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced [
    Moscoso A; Grothe MJ; Schöll M;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2283-2294. PubMed ID: 33475761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [
    O'Connor A; Cash DM; Poole T; Markiewicz PJ; Fraser MR; Malone IB; Jiao J; Weston PSJ; Flores S; Hornbeck R; McDade E; Schöll M; Gordon BA; Bateman RJ; Benzinger TLS; Fox NC
    Alzheimers Res Ther; 2023 May; 15(1):99. PubMed ID: 37231491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensating for choroid plexus based off-target signal in the hippocampus using
    Pawlik D; Leuzy A; Strandberg O; Smith R
    Neuroimage; 2020 Nov; 221():117193. PubMed ID: 32711062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing quantification of MK6240 tau PET in unimpaired older adults.
    Harrison TM; Ward TJ; Murphy A; Baker SL; Dominguez PA; Koeppe R; Vemuri P; Lockhart SN; Jung Y; Harvey DJ; Lovato L; Toga AW; Masdeu J; Oh H; Gitelman DR; Aggarwal N; Snyder HM; Baker LD; DeCarli C; Jagust WJ; Landau SM;
    Neuroimage; 2023 Jan; 265():119761. PubMed ID: 36455762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults.
    McSweeney M; Pichet Binette A; Meyer PF; Gonneaud J; Bedetti C; Ozlen H; Labonté A; Rosa-Neto P; Breitner J; Poirier J; Villeneuve S;
    Neurology; 2020 Mar; 94(11):e1190-e1200. PubMed ID: 32015176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.